Corrigendum to “Genetics Variants and Serum Levels of MHC Class I Chain-related A in Predicting Hepatocellular Carcinoma Development in Chronic Hepatitis C Patients Post Antiviral Treatment” [EBioMedicine 15 (2017) 81–89]

Bibliographic Details
Main Authors:	Chung-Feng Huang, Ching-I Huang, Ming-Lun Yeh, Shu-Chi Wang, Kuan-Yu Chen, Yu-Min Ko, Ching-Chih Lin, Yi-Shan Tsai, Pei-Chien Tsai, Zu-Yau Lin, Shinn-Cherng Chen, Chia-Yen Dai, Jee-Fu Huang, Wan-Long Chuang, Ming-Lung Yu
Format:	Article
Language:	English
Published:	Elsevier 2017-03-01
Series:	EBioMedicine
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352396417300865

id	doaj-5e2c0d04ea814ded85210d58ed66b144
record_format	Article
spelling	doaj-5e2c0d04ea814ded85210d58ed66b1442020-11-25T01:33:20ZengElsevierEBioMedicine2352-39642017-03-0117C23710.1016/j.ebiom.2017.02.027Corrigendum to “Genetics Variants and Serum Levels of MHC Class I Chain-related A in Predicting Hepatocellular Carcinoma Development in Chronic Hepatitis C Patients Post Antiviral Treatment” [EBioMedicine 15 (2017) 81–89]Chung-Feng Huang0Ching-I Huang1Ming-Lun Yeh2Shu-Chi Wang3Kuan-Yu Chen4Yu-Min Ko5Ching-Chih Lin6Yi-Shan Tsai7Pei-Chien Tsai8Zu-Yau Lin9Shinn-Cherng Chen10Chia-Yen Dai11Jee-Fu Huang12Wan-Long Chuang13Ming-Lung Yu14Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, TaiwanHepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, TaiwanHepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, TaiwanHepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, TaiwanHepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, TaiwanHepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, TaiwanHepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, TaiwanHepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, TaiwanHepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, TaiwanHepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, TaiwanHepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, TaiwanHepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, TaiwanHepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, TaiwanHepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, TaiwanHepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwanhttp://www.sciencedirect.com/science/article/pii/S2352396417300865
collection	DOAJ
language	English
format	Article
sources	DOAJ
author	Chung-Feng Huang Ching-I Huang Ming-Lun Yeh Shu-Chi Wang Kuan-Yu Chen Yu-Min Ko Ching-Chih Lin Yi-Shan Tsai Pei-Chien Tsai Zu-Yau Lin Shinn-Cherng Chen Chia-Yen Dai Jee-Fu Huang Wan-Long Chuang Ming-Lung Yu
spellingShingle	Chung-Feng Huang Ching-I Huang Ming-Lun Yeh Shu-Chi Wang Kuan-Yu Chen Yu-Min Ko Ching-Chih Lin Yi-Shan Tsai Pei-Chien Tsai Zu-Yau Lin Shinn-Cherng Chen Chia-Yen Dai Jee-Fu Huang Wan-Long Chuang Ming-Lung Yu Corrigendum to “Genetics Variants and Serum Levels of MHC Class I Chain-related A in Predicting Hepatocellular Carcinoma Development in Chronic Hepatitis C Patients Post Antiviral Treatment” [EBioMedicine 15 (2017) 81–89] EBioMedicine
author_facet	Chung-Feng Huang Ching-I Huang Ming-Lun Yeh Shu-Chi Wang Kuan-Yu Chen Yu-Min Ko Ching-Chih Lin Yi-Shan Tsai Pei-Chien Tsai Zu-Yau Lin Shinn-Cherng Chen Chia-Yen Dai Jee-Fu Huang Wan-Long Chuang Ming-Lung Yu
author_sort	Chung-Feng Huang
title	Corrigendum to “Genetics Variants and Serum Levels of MHC Class I Chain-related A in Predicting Hepatocellular Carcinoma Development in Chronic Hepatitis C Patients Post Antiviral Treatment” [EBioMedicine 15 (2017) 81–89]
title_short	Corrigendum to “Genetics Variants and Serum Levels of MHC Class I Chain-related A in Predicting Hepatocellular Carcinoma Development in Chronic Hepatitis C Patients Post Antiviral Treatment” [EBioMedicine 15 (2017) 81–89]
title_full	Corrigendum to “Genetics Variants and Serum Levels of MHC Class I Chain-related A in Predicting Hepatocellular Carcinoma Development in Chronic Hepatitis C Patients Post Antiviral Treatment” [EBioMedicine 15 (2017) 81–89]
title_fullStr	Corrigendum to “Genetics Variants and Serum Levels of MHC Class I Chain-related A in Predicting Hepatocellular Carcinoma Development in Chronic Hepatitis C Patients Post Antiviral Treatment” [EBioMedicine 15 (2017) 81–89]
title_full_unstemmed	Corrigendum to “Genetics Variants and Serum Levels of MHC Class I Chain-related A in Predicting Hepatocellular Carcinoma Development in Chronic Hepatitis C Patients Post Antiviral Treatment” [EBioMedicine 15 (2017) 81–89]
title_sort	corrigendum to “genetics variants and serum levels of mhc class i chain-related a in predicting hepatocellular carcinoma development in chronic hepatitis c patients post antiviral treatment” [ebiomedicine 15 (2017) 81–89]
publisher	Elsevier
series	EBioMedicine
issn	2352-3964
publishDate	2017-03-01
url	http://www.sciencedirect.com/science/article/pii/S2352396417300865
work_keys_str_mv	AT chungfenghuang corrigendumtogeneticsvariantsandserumlevelsofmhcclassichainrelatedainpredictinghepatocellularcarcinomadevelopmentinchronichepatitiscpatientspostantiviraltreatmentebiomedicine1520178189 AT chingihuang corrigendumtogeneticsvariantsandserumlevelsofmhcclassichainrelatedainpredictinghepatocellularcarcinomadevelopmentinchronichepatitiscpatientspostantiviraltreatmentebiomedicine1520178189 AT minglunyeh corrigendumtogeneticsvariantsandserumlevelsofmhcclassichainrelatedainpredictinghepatocellularcarcinomadevelopmentinchronichepatitiscpatientspostantiviraltreatmentebiomedicine1520178189 AT shuchiwang corrigendumtogeneticsvariantsandserumlevelsofmhcclassichainrelatedainpredictinghepatocellularcarcinomadevelopmentinchronichepatitiscpatientspostantiviraltreatmentebiomedicine1520178189 AT kuanyuchen corrigendumtogeneticsvariantsandserumlevelsofmhcclassichainrelatedainpredictinghepatocellularcarcinomadevelopmentinchronichepatitiscpatientspostantiviraltreatmentebiomedicine1520178189 AT yuminko corrigendumtogeneticsvariantsandserumlevelsofmhcclassichainrelatedainpredictinghepatocellularcarcinomadevelopmentinchronichepatitiscpatientspostantiviraltreatmentebiomedicine1520178189 AT chingchihlin corrigendumtogeneticsvariantsandserumlevelsofmhcclassichainrelatedainpredictinghepatocellularcarcinomadevelopmentinchronichepatitiscpatientspostantiviraltreatmentebiomedicine1520178189 AT yishantsai corrigendumtogeneticsvariantsandserumlevelsofmhcclassichainrelatedainpredictinghepatocellularcarcinomadevelopmentinchronichepatitiscpatientspostantiviraltreatmentebiomedicine1520178189 AT peichientsai corrigendumtogeneticsvariantsandserumlevelsofmhcclassichainrelatedainpredictinghepatocellularcarcinomadevelopmentinchronichepatitiscpatientspostantiviraltreatmentebiomedicine1520178189 AT zuyaulin corrigendumtogeneticsvariantsandserumlevelsofmhcclassichainrelatedainpredictinghepatocellularcarcinomadevelopmentinchronichepatitiscpatientspostantiviraltreatmentebiomedicine1520178189 AT shinncherngchen corrigendumtogeneticsvariantsandserumlevelsofmhcclassichainrelatedainpredictinghepatocellularcarcinomadevelopmentinchronichepatitiscpatientspostantiviraltreatmentebiomedicine1520178189 AT chiayendai corrigendumtogeneticsvariantsandserumlevelsofmhcclassichainrelatedainpredictinghepatocellularcarcinomadevelopmentinchronichepatitiscpatientspostantiviraltreatmentebiomedicine1520178189 AT jeefuhuang corrigendumtogeneticsvariantsandserumlevelsofmhcclassichainrelatedainpredictinghepatocellularcarcinomadevelopmentinchronichepatitiscpatientspostantiviraltreatmentebiomedicine1520178189 AT wanlongchuang corrigendumtogeneticsvariantsandserumlevelsofmhcclassichainrelatedainpredictinghepatocellularcarcinomadevelopmentinchronichepatitiscpatientspostantiviraltreatmentebiomedicine1520178189 AT minglungyu corrigendumtogeneticsvariantsandserumlevelsofmhcclassichainrelatedainpredictinghepatocellularcarcinomadevelopmentinchronichepatitiscpatientspostantiviraltreatmentebiomedicine1520178189
_version_	1725077803123081216

Corrigendum to “Genetics Variants and Serum Levels of MHC Class I Chain-related A in Predicting Hepatocellular Carcinoma Development in Chronic Hepatitis C Patients Post Antiviral Treatment” [EBioMedicine 15 (2017) 81–89]

Similar Items